Two Sigma Investments
ACOR

Two Sigma Investments’s Acorda Therapeutics ACOR Stock Holding History

Two Sigma Investments’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,354
Closed -$15.9K – 3410
2023
Q1 		$15.9K Sell
1,354
-109
-7% -$1.81K ﹤0.01% 2865
2022
Q4 		$22.4K Buy
1,463
+38
+3% +$443 ﹤0.01% 2669
2022
Q3 		$9K Buy
+1,425
New +$11.9K ﹤0.01% 2418
2021
Q4 		– Sell
-543
Closed -$50K – 5072
2021
Q3 		$50K Buy
+543
New +$45K ﹤0.01% 4148
2020
Q3 		– Sell
-1,574
Closed -$139K – 3691
2020
Q2 		$139K Sell
1,574
-2,660
-63% -$281K ﹤0.01% 2737
2020
Q1 		$474K Sell
4,234
-1,112
-21% -$219K ﹤0.01% 1975
2019
Q4 		$1.31M Buy
5,346
+3,536
+195% +$892K ﹤0.01% 1943
2019
Q3 		$623K Sell
1,810
-2,840
-61% -$1.54M ﹤0.01% 2369
2019
Q2 		$4.28M Buy
4,650
+1,628
+54% +$2M 0.01% 969
2019
Q1 		$4.82M Buy
3,022
+1,680
+125% +$3.03M 0.02% 980
2018
Q4 		$2.51M Buy
+1,342
New +$2.92M 0.01% 1140
2018
Q3 		– Sell
-1,472
Closed -$5.07M – 3714
2018
Q2 		$5.07M Buy
+1,472
New +$4.51M 0.02% 1013
2017
Q2 		– Sell
-1,411
Closed -$3.56M – 3369
2017
Q1 		$3.56M Sell
1,411
-1,521
-52% -$4.38M 0.01% 1115
2016
Q4 		$6.61M Buy
2,932
+974
+50% +$2.32M 0.03% 709
2016
Q3 		$4.91M Sell
1,958
-1,445
-42% -$4.31M 0.02% 886
2016
Q2 		$10.4M Sell
3,403
-797
-19% -$2.59M 0.04% 463
2016
Q1 		$13.3M Buy
4,200
+2,568
+157% +$10.7M 0.06% 363
2015
Q4 		$8.38M Buy
+1,632
New +$7.13M 0.04% 482
2015
Q2 		– Sell
-1,168
Closed -$4.66M – 3174
2015
Q1 		$4.66M Buy
1,168
+1,031
+753% +$4.72M 0.02% 754
2014
Q4 		$673K Sell
137
-476
-78% -$2.04M ﹤0.01% 1578
2014
Q3 		$2.49M Buy
613
+93
+18% +$349K 0.01% 813
2014
Q2 		$2.1M Sell
520
-117
-18% -$477K 0.01% 1006
2014
Q1 		$2.9M Buy
637
+281
+79% +$1.14M 0.02% 811
2013
Q4 		$1.25M Buy
+356
New +$1.39M 0.01% 1225

Other funds holding ACOR

DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Two Sigma Investments's ACOR Position: Q2 2023 in Review

Two Sigma Investments sold out of Acorda Therapeutics (ACOR) in Q2 2023, closing a stake of 1,354 shares — an estimated $15.9K sold.

Two Sigma Investments first reported a position in ACOR in Q4 2013 and held it in 24 quarters. The position peaked at $13.3M in Q1 2016. 15 funds tracked by Wall St. Rank hold ACOR as of Q2 2023.

  • Two Sigma Investments reported no remaining Acorda Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Investments sold 1,354 Acorda Therapeutics shares in Q2 2023, an estimated $15.9K.
  • Two Sigma Investments first reported a position in Acorda Therapeutics in Q4 2013 and held it in 24 quarters.
  • Two Sigma Investments's Acorda Therapeutics position peaked at $13.3M in Q1 2016.
  • 15 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.